Julie Grisham, MS

Freelance Science Writer

Recent Blog Posts

Pictured: Viviane Tabar
In the Lab
Monday, December 1, 2014

Investigators have created the first-ever genetically engineered model of cancer made from human embryonic stem cells in culture.

Michel Sadelain and Prasad Adusumilli
Finding
Wednesday, November 19, 2014

A study in mouse models suggests how modified T cells may be used to treat tumors in the area just outside the lungs.

(From left) MSK investigators Michael Berger, José Baselga, and Maurizio Scaltriti, and graduate student Pau Castel.
Finding
Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
Thursday, November 13, 2014

In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.

Pictured: Joao Xavier & Eric Pamer
In the Lab
Monday, November 10, 2014

Clostridium difficile infections are a growing problem, but MSK researchers are looking for innovative ways to prevent and treat them.

A student asks a question at last year’s "Major Trends” seminar.
Event
Monday, November 3, 2014

Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.

SUPPORT
Thursday, October 23, 2014

MSK medical oncologist and acupuncturist Ting Bao discusses the symptoms that arise during breast cancer treatment and how integrative medicine may help relieve them.

Giving
Thursday, October 16, 2014

For family and friends looking to contribute in any way they can, giving blood on behalf of a particular patient can be a great help.

DNA wrapped around histones
Decoder
Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Experimental Brain Tumor
In the Lab
Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Pictured: David Abramson
In the Clinic
Monday, September 15, 2014

Retinoblastoma expert David Abramson discusses how treatments and survival rates have greatly improved for this rare pediatric eye cancer.

In the Lab
Thursday, September 4, 2014

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

In the Lab
Monday, July 28, 2014

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.